BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6458673)

  • 1. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
    Kaplan SL; Mason EO; Garcia H; Kvernland SJ; Loiselle EM; Anderson DC; Mintz AA; Feigin RD
    J Pediatr; 1981 Jan; 98(1):152-7. PubMed ID: 6450278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxalactam for the treatment of bacterial meningitis in children.
    Freedman JM; Hoffman SH; Scheld WM; Lynch MA; da Silva HR; Rocha H; Sande MA
    J Infect Dis; 1983 Nov; 148(5):886-91. PubMed ID: 6415181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential value of cefoperazone in bacterial meningitis: experimental studies.
    Durack DT; Perfect JR
    Drugs; 1981; 22 Suppl 1():60-4. PubMed ID: 6269824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial meningitis. Effect of antibiotic treatment on cerebrospinal fluid.
    Blazer S; Berant M; Alon U
    Am J Clin Pathol; 1983 Sep; 80(3):386-7. PubMed ID: 6881104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of moxalactam into CSF.
    Landesman SH
    J Pediatr; 1982 Jul; 101(1):160-1. PubMed ID: 6211532
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid penetration of cefmenoxime in children with bacterial meningitis.
    Eicken A; Schöber JG; Roos R; Machka K
    Infection; 1991; 19(6):406-8. PubMed ID: 1816111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
    Nix WA; Hey O; Fabricius K
    Nervenarzt; 1982 Dec; 53(12):693-700. PubMed ID: 6218415
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Cherubin CC; Gombert M; Cleri D
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute bacterial meningitis with absent or minimal cerebrospinal fluid abnormalities. A report of three cases.
    Moore CM; Ross M
    Clin Pediatr (Phila); 1973 Feb; 12(2):117-8. PubMed ID: 4539954
    [No Abstract]   [Full Text] [Related]  

  • 20. Moxalactam therapy of Haemophilus influenzae type b meningitis in children.
    Chartrand SA; Marks MI; Scribner RK; Johnston JT; Frederick DF
    J Pediatr; 1984 Mar; 104(3):454-9. PubMed ID: 6608581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.